Last quarter (Q3 2025), Day One Biopharmaceuticals's total revenue was $39.80M, a decrease of -57.56% from the same quarter last year. In Q3, Day One Biopharmaceuticals's net income was $-19.73M. See Day One Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 131.16M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 125.88M	$ -383.00K	$ -531.00K	$ -199.00K	$ -155.00K
Operating Expenses	$ 343.15M	$ 205.68M	$ 146.38M	$ 72.54M	$ 13.63M
Depreciation and Amortization	$ 2.03M	$ 383.00K	$ 531.00K	$ 199.00K	$ 155.00K
EBITDA	$ -86.32M	$ -188.53M	$ -141.65M	$ -72.56M	$ -43.66M
Operating Income	$ -217.27M	$ -206.06M	$ -146.91M	$ -72.74M	$ -13.78M
Other Income/Expenses	$ 128.92M	$ 17.15M	$ 4.73M	$ -11.00K	$ -30.06M
Pretax Income	$ -88.35M	$ -188.92M	$ -142.18M	$ -72.75M	$ -43.84M
Net Income	$ -95.50M	$ -188.92M	$ -142.18M	$ -70.64M	$ -40.51M
Per Share Metrics
Basic EPS	$ -1.02	$ -2.37	$ -2.02	$ -1.14	$ -0.65
Diluted EPS	$ -1.02	$ -2.37	$ -2.02	$ -1.14	$ -0.65
Weighted Average Shares Outstanding	93.62M	79.77M	65.47M	61.95M	61.93M
Weighted Average Shares Outstanding (Diluted)	93.62M	79.77M	65.47M	61.95M	61.93M

Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing